40 results on '"Unmehopa U"'
Search Results
2. A free-choice high-fat diet modulates the effects of a sucrose bolus on the expression of genes involved in glucose handling in the hypothalamus and nucleus accumbens
- Author
-
Koekkoek, L L, Unmehopa, U A, Eggels, L, Kool, T, Lamuadni, K, Diepenbroek, C, Mul, J D, Serlie, M J, la Fleur, S E, Koekkoek, L L, Unmehopa, U A, Eggels, L, Kool, T, Lamuadni, K, Diepenbroek, C, Mul, J D, Serlie, M J, and la Fleur, S E
- Abstract
The consumption of saturated fat and sucrose can have synergistic effects on the brain that do not occur when either nutrient is consumed by itself. In this study we hypothesize that saturated fat intake modulates glucose handling in the hypothalamus and nucleus accumbens, both brain areas highly involved in the control of food intake. To study this, male Wistar rats were given a free-choice high fat diet (fcHFD) or a control diet for two weeks. During the last seven days rats were given a daily bolus of either a 30% sucrose solution or water. Rats were sacrificed on day eight, 30 minutes after the onset of drinking. mRNA and protein levels of genes involved in glucose handling were assessed in the hypothalamus and nucleus accumbens. We found increased Glut3 and Glut4 mRNA in the hypothalamus of fcHFD-fed rats without an additional effect of the sucrose bolus. In the nucleus accumbens, the sucrose bolus increased Glut3 mRNA and decreased Glut4 mRNA independent of prior diet exposure. The ATP-sensitive potassium channel subunit Kir6.1 in the nucleus accumbens tended to be affected by the synergistic effects of a fcHFD and a sucrose bolus. These data suggest that acute glucose handling in the hypothalamus and nucleus accumbens may be affected by prior high fat exposure.
- Published
- 2020
3. Neuropeptide Y Signaling in the Lateral Hypothalamus Modulates Diet Component Selection and is Dysregulated in a Model of Diet-Induced Obesity
- Author
-
Gumbs, M C R, Eggels, L, Kool, T, Unmehopa, U A, van den Heuvel, J K, Lamuadni, K, Mul, J D, la Fleur, S E, Gumbs, M C R, Eggels, L, Kool, T, Unmehopa, U A, van den Heuvel, J K, Lamuadni, K, Mul, J D, and la Fleur, S E
- Abstract
The preclinical multicomponent free-choice high-fat high-sucrose (fcHFHS) diet has strong validity to model diet-induced obesity (DIO) and associated maladaptive molecular changes in the central nervous system. fcHFHS-induced obese rats demonstrate increased sensitivity to intracerebroventricular infusion of the orexigenic Neuropeptide Y (NPY). The brain region-specific effects of NPY signaling on fcHFHS diet component selection are not completely understood. For example, fcHFHS-fed rats have increased intake of chow and fat following intracerebroventricular NPY infusion, whereas NPY administration in the nucleus accumbens, a key hub of the reward circuitry, specifically increases fat intake. Here, we investigated whether NPY infusion in the lateral hypothalamic area (LHA), which is crucially involved in the regulation of intake, regulates fcHFHS component selection, and if LHA NPY receptor subtypes 1 or 5 (NPYR1/5) are involved. Male Wistar rats were fed a chow or fcHFHS diet for at least seven days and received intra-LHA vehicle or NPY infusions in a cross-over design. Diet component intake was measured two hours later. Separate experimental designs were used to test the efficacy of NPY1R- or NPY5R antagonism to prevent the orexigenic effects of intra-LHA NPY. Intra-LHA NPY increased caloric intake in chow- and fcHFHS-fed rats. This effect was mediated specifically by chow intake in fcHFHS-fed rats. The orexigenic effects of intra-LHA NPY were prevented by NPY1R and NPY5R antagonism in chow-fed rats, but only by NPY5R antagonism in fcHFHS-fed rats. Thus, NPY signaling has brain region-specific effects on fcHFHS component selection and LHA NPYR sensitivity is dysregulated during consumption of a fcHFHS diet.
- Published
- 2020
4. Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in the Human Hypothalamus
- Author
-
Bisschop, P. H., Dekker, M. J. H. J., Osterthun, W., Kwakkel, J., Anink, J. J., Boelen, A., Unmehopa, U. A., Koper, J. W., Lamberts, S. W. J., Stewart, P. M., Swaab, D. F., and Fliers, E.
- Published
- 2013
- Full Text
- View/download PDF
5. Hypothalamic Vasopressin and Oxytocin mRNA Expression in Relation to Depressive State in Alzheimerʼs Disease: A Difference With Major Depressive Disorder
- Author
-
Meynen, G., Unmehopa, U. A., Hofman, M. A., Swaab, D. F., and Hoogendijk, W. J. G.
- Published
- 2009
- Full Text
- View/download PDF
6. Hypothalamic oxytocin mRNA expression and melancholic depression
- Author
-
Meynen, G, Unmehopa, U A, Hofman, M A, Swaab, D F, and Hoogendijk, W JG
- Published
- 2007
7. Glucocorticoids Decrease Thyrotropin-Releasing Hormone Messenger Ribonucleic Acid Expression in the Paraventricular Nucleus of the Human Hypothalamus
- Author
-
Alkemade, A, Unmehopa, U A., Wiersinga, W M., Swaab, D F., and Fliers, E
- Published
- 2005
8. One-week exposure to a free-choice high-fat high-sugar diet does not disrupt blood-brain barrier permeability in fed or overnight fasted rats
- Author
-
Rijnsburger, M., Unmehopa, U A, Eggels, L., Serlie, Mireille J, la Fleur, S E, Rijnsburger, M., Unmehopa, U A, Eggels, L., Serlie, Mireille J, and la Fleur, S E
- Abstract
OBJECTIVES: The hypothalamus lies adjacent to the third ventricle and is in close proximity with the median eminence (ME), a circumventricular organ with an incomplete blood-brain barrier (BBB) which controls direct entry of nutrients into the brain. The blood-CSF barrier of the hypothalamus shows dynamic changes upon neuroendocrine events and adjusts permeability with the tight junction (TJ) complex. It has been shown that chronic exposure to a high-fat diet (HFD) affects BBB permeability. HFD also induces leptin resistance and alters neuropeptide expression in the arcuate nucleus (Arc) of the hypothalamus starting early during overnutrition. We hypothesized altered integrity of the BBB to occur after exposing rats to a free-choice high-fat high-sugar (fcHFHS) diet for 1 week.METHODS: We measured diffusion of Evans blue dye over the ME and assessed expression of the TJ proteins ZO-1, claudin-5, and occludin in the tanycytic wall of the third ventricle. Furthermore, we assessed protein expression of glucose transporter 1 (GLUT-1), which is highly expressed in the Arc-ME complex and facilitates glucose transport over the BBB.RESULTS: fcHFHS-fed rats increased caloric intake compared to control, however, there was no effect of the fcHFHS diet on permeability of the BBB, nor changes in protein expression of tight TJ proteins or GLUT-1. Fasting acutely affects the BBB and we hypothesized that exposure to the fcHFHS diet affects the BBB differently compared to chow after fasting. We did not, however, find any differences in Evans blue diffusion nor protein expression between chow- and fcHFHS-fed rats when fasted overnight.CONCLUSIONS: We conclude that short-term consumption of a fcHFHS diet does not change permeability or diffusion in the hypothalamus barrier in ad libitum fed or fasted rats.
- Published
- 2019
9. Decreased thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus of patients with major depression
- Author
-
Alkemade, A, Unmehopa, U A, Brouwer, J P, Hoogendijk, W JG, Wiersinga, W M, Swaab, D F, and Fliers, E
- Published
- 2003
10. TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans
- Author
-
Nies, V. J. M., Nies, V. J. M., Struik, D., Wolfs, M. G. M., Rensen, S. S., Szalowska, E., Unmehopa, U. A., Fluiter, K., van der Meer, T. P., Hajmousa, G., Buurman, W. A., Greve, J. W., Rezaee, F., Shiri-Sverdlov, R., Vonk, R. J., Swaab, D. F., Wolffenbuttel, B. H. R., Jonker, J. W., van Vliet-Ostaptchouk, J. V., Nies, V. J. M., Nies, V. J. M., Struik, D., Wolfs, M. G. M., Rensen, S. S., Szalowska, E., Unmehopa, U. A., Fluiter, K., van der Meer, T. P., Hajmousa, G., Buurman, W. A., Greve, J. W., Rezaee, F., Shiri-Sverdlov, R., Vonk, R. J., Swaab, D. F., Wolffenbuttel, B. H. R., Jonker, J. W., and van Vliet-Ostaptchouk, J. V.
- Abstract
BACKGROUND/OBJECTIVES: Mutations in the Tubby gene (TUB) cause late-onset obesity and insulin resistance in mice and syndromic obesity in humans. Although TUB gene function has not yet been fully elucidated, studies in rodents indicate that TUB is involved in the hypothalamic pathways regulating food intake and adiposity. Aside from the function in central nervous system, TUB has also been implicated in energy metabolism in adipose tissue in rodents. We aimed to determine the expression and distribution patterns of TUB in man as well as its potential association with obesity.SUBJECTS/METHODS: In situ hybridization was used to localize the hypothalamic regions and cells expressing TUB mRNA. Using RT-PCR, we determined the mRNA expression level of the two TUB gene alternative splicing isoforms, the short and the long transcript variants, in the hypothalami of 12 obese and 12 normal-weight subjects, and in biopsies from visceral (VAT) and subcutaneous (SAT) adipose tissues from 53 severely obese and 24 non-obese control subjects, and correlated TUB expression with parameters of obesity and metabolic health.RESULTS: Expression of both TUB transcripts was detected in the hypothalamus, whereas only the short TUB isoform was found in both VAT and SAT. TUB mRNA was detected in several hypothalamic regions involved in body weight regulation, including the nucleus basalis of Meynert and the paraventricular, supraoptic and tuberomammillary nuclei. We found no difference in the hypothalamic TUB expression between obese and control groups, whereas the level of TUB mRNA was significantly lower in adipose tissue of obese subjects as compared to controls. Also, TUB expression was negatively correlated with indices of body weight and obesity in a fat-depot-specific manner.CONCLUSIONS: Our results indicate high expression of TUB in the hypothalamus, especially in areas involved in body weight regulation, and the correlation between TUB expression in adipose ti
- Published
- 2018
11. TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans
- Author
-
Nies, V J M, Struik, D, Wolfs, M G M, Rensen, S S, Szalowska, E, Unmehopa, U A, Fluiter, K., van der Meer, T P, Hajmousa, G, Buurman, W A, Greve, J W, Rezaee, F, Shiri-Sverdlov, R, Vonk, R.J., Swaab, D F, Wolffenbuttel, B H R, Jonker, J.W., van Vliet-Ostaptchouk, J V, Nies, V J M, Struik, D, Wolfs, M G M, Rensen, S S, Szalowska, E, Unmehopa, U A, Fluiter, K., van der Meer, T P, Hajmousa, G, Buurman, W A, Greve, J W, Rezaee, F, Shiri-Sverdlov, R, Vonk, R.J., Swaab, D F, Wolffenbuttel, B H R, Jonker, J.W., and van Vliet-Ostaptchouk, J V
- Abstract
BACKGROUND/OBJECTIVES: Mutations in the Tubby gene (TUB) cause late-onset obesity and insulin resistance in mice and syndromic obesity in humans. Although TUB gene function has not yet been fully elucidated, studies in rodents indicate that TUB is involved in the hypothalamic pathways regulating food intake and adiposity. Aside from the function in central nervous system, TUB has also been implicated in energy metabolism in adipose tissue in rodents. We aimed to determine the expression and distribution patterns of TUB in man as well as its potential association with obesity.SUBJECTS/METHODS: In situ hybridization was used to localize the hypothalamic regions and cells expressing TUB mRNA. Using RT-PCR, we determined the mRNA expression level of the two TUB gene alternative splicing isoforms, the short and the long transcript variants, in the hypothalami of 12 obese and 12 normal-weight subjects, and in biopsies from visceral (VAT) and subcutaneous (SAT) adipose tissues from 53 severely obese and 24 non-obese control subjects, and correlated TUB expression with parameters of obesity and metabolic health.RESULTS: Expression of both TUB transcripts was detected in the hypothalamus, while only the short TUB isoform was found in both VAT and SAT. TUB mRNA was detected in several hypothalamic regions involved in body weight regulation, including the nucleus basalis of Meynert and the paraventricular, supraoptic and tuberomammillary nuclei. We found no difference in the hypothalamic TUB expression between obese and control groups, while the level of TUB mRNA was significantly lower in adipose tissue of obese subjects as compared to controls. Also, TUB expression was negatively correlated with indices of body weight and obesity in a fat-depot-specific manner.CONCLUSIONS: Our results indicate high expression of TUB in the hypothalamus, especially in areas involved in body weight regulation, and the correlation between TUB expression in adipose tissue
- Published
- 2018
12. One-week exposure to a free-choice high-fat high-sugar diet does not disrupt blood–brain barrier permeability in fed or overnight fasted rats
- Author
-
Rijnsburger, M., primary, Unmehopa, U. A., additional, Eggels, L., additional, Serlie, M. J., additional, and la Fleur, S. E., additional
- Published
- 2017
- Full Text
- View/download PDF
13. TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans
- Author
-
Nies, V J M, primary, Struik, D, additional, Wolfs, M G M, additional, Rensen, S S, additional, Szalowska, E, additional, Unmehopa, U A, additional, Fluiter, K, additional, van der Meer, T P, additional, Hajmousa, G, additional, Buurman, W A, additional, Greve, J W, additional, Rezaee, F, additional, Shiri-Sverdlov, R, additional, Vonk, R J, additional, Swaab, D F, additional, Wolffenbuttel, B H R, additional, Jonker, J W, additional, and van Vliet-Ostaptchouk, J V, additional
- Published
- 2017
- Full Text
- View/download PDF
14. Impact of obesity on taste receptor expression in extra-oral tissues: emphasis on hypothalamus and brainstem
- Author
-
Herrera Moro Chao, D., primary, Argmann, C., additional, Van Eijk, M., additional, Boot, R. G., additional, Ottenhoff, R., additional, Van Roomen, C., additional, Foppen, E., additional, Siljee, J. E., additional, Unmehopa, U. A., additional, Kalsbeek, A., additional, and Aerts, J. M. F. G., additional
- Published
- 2016
- Full Text
- View/download PDF
15. Individual differences in the expression of tyrosine hydroxylase mRNA in neurosecretory neurons of the human paraventricular and supraoptic nuclei: Positive correlation with vasopressin mRNA
- Author
-
Panayotacopoulou, M.T. Malidelis, Y. Van Heerikhuize, J. Unmehopa, U. Swaab, D.
- Subjects
nervous system - Abstract
Previous studies indicated that in the human paraventricular nucleus (PVN) and in the supraoptic nucleus (SON) tyrosine hydroxylase (TH) - the first and rate-limiting enzyme in catecholamine synthesis - is localized mainly in magnocellular neurosecretory neurons. Individual differences were observed among control subjects in number and distribution of TH-immunoreactive (IR) perikarya, indicating that antemortem factors may regulate TH expression. Since a large number of TH-IR perikarya were observed in subjects who suffered from somatic illnesses leading to prolonged osmotic or non-osmotic stimulation of vasopressin (VP) release, we suggested that TH expression is related to the activation of VP neurons. The purpose of our study was to apply (1) in situ hybridization for TH mRNA on human PVN and SON to investigate how the previously reported individual differences in TH protein expression are depicted at the transcriptional level and (2) quantitative TH immunohistochemistry and in situ hybridization for VP mRNA throughout the dorsolateral part of the SON (dl-SON) in order to elucidate whether indeed expression of TH in neurosecretory nuclei depends on activation of VP neurons. Postmortem formalin-fixed, paraffin-embedded hypothalamic sections of 16 control subjects were studied for TH protein and TH and VP mRNAs. For 6 of the above cases, the number of TH-IR neurons and the total VP mRNA levels were estimated throughout the entire dl-SON using an image analysis system. Individual variation was observed in TH mRNA expression which appears to parallel the expression of TH-protein. Using Spearman's bivariate test, a positive correlation was found between the number of TH-IR- and TH-mRNA-expressing neurons in both PVN and SON (p < 0.01) as well as between the number of TH-IR neurons and the total VP mRNA in the dl-SON (p < 0.05). Our results show (1) that the individual variability in the number of TH-IR neurons within the neurosecretory nuclei might be due to differential expression and/or stability of TH mRNA and (2) that expression of TH-immunoreactivity in human PVN and SON depends on the activation of VP neurons. Copyright © 2005 S. Karger AG.
- Published
- 2005
16. Hypothalamic neuropeptides and regulation of fat mass in prader-willi syndrome
- Author
-
Goldstone, A. P., Unmehopa, U. A., Thomas, E. L., Brynes, A. E., Bell, J. D., Frost, G., Ghatei, M. A., Holland, A., Bloom, S. R., Swaab, D. F., Eiholzer, U., l'Allemand, D., Zipf, W. B., and Other departments
- Published
- 2003
17. Decreased neuropeptide Y (NPY) expression in the infundibular nucleus of patients with nonthyroidal illness
- Author
-
Fliers, E., Unmehopa, U., Manniesing, S., Wiersinga, W.M., Swaab, D.F., and Netherlands Institute for Neuroscience (NIN)
- Published
- 2001
18. Metabolic activity of the human ventromedial nucleus neurons in relation to sex and aging
- Author
-
Ishunina, T.A., Unmehopa, U., Heerikhuize, J.J. van, Pool, C.W., Swaab, D.F., and Netherlands Institute for Neuroscience (NIN)
- Published
- 2001
19. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone.
- Author
-
Wu, Y.-H., Zhou, J.-N., Balesar, R., Unmehopa, U., Bao, A., Jockers, R., Heerikhuize, J., Swaab, D.F., Wu, Y.-H., Zhou, J.-N., Balesar, R., Unmehopa, U., Bao, A., Jockers, R., Heerikhuize, J., and Swaab, D.F.
- Abstract
Melatonin is implicated in numerous physiological processes, including circadian rhythms, stress, and reproduction, many of which are mediated by the hypothalamus and pituitary. The physiological actions of melatonin are mainly mediated by melatonin receptors. We here describe the distribution of the melatonin receptor MT1 in the human hypothalamus and pituitary by immunocytochemistry. MT1 immunoreactivity showed a widespread pattern in the hypothalamus. In addition to the area of the suprachiasmatic nucleus (SCN), a number of novel sites, including the paraventricular nucleus (PVN), periventricular nucleus, supraoptic nucleus (SON), sexually dimorphic nucleus, the diagonal band of Broca, the nucleus basalis of Meynert, infundibular nucleus, ventromedial and dorsomedial nucleus, tuberomamillary nucleus, mamillary body, and paraventricular thalamic nucleus were observed to have neuronal MT1 receptor expression. No staining was observed in the nucleus tuberalis lateralis and bed nucleus of the stria terminalis. The MT1 receptor was colocalized with some vasopressin (AVP) neurons in the SCN, colocalized with some parvocellular and magnocellular AVP and oxytocine (OXT) neurons in the PVN and SON, and colocalized with some parvocellular corticotropin-releasing hormone (CRH) neurons in the PVN. In the pituitary, strong MT1 expression was observed in the pars tuberalis, while a weak staining was found in the posterior and anterior pituitary. These findings provide a neurobiological basis for the participation of melatonin in the regulation of various hypothalamic and pituitary functions. The colocalization of MT1 and CRH suggests that melatonin might directly modulate the hypothalamus-pituitary-adrenal axis in the PVN, which may have implications for stress conditions such as depression., Melatonin is implicated in numerous physiological processes, including circadian rhythms, stress, and reproduction, many of which are mediated by the hypothalamus and pituitary. The physiological actions of melatonin are mainly mediated by melatonin receptors. We here describe the distribution of the melatonin receptor MT1 in the human hypothalamus and pituitary by immunocytochemistry. MT1 immunoreactivity showed a widespread pattern in the hypothalamus. In addition to the area of the suprachiasmatic nucleus (SCN), a number of novel sites, including the paraventricular nucleus (PVN), periventricular nucleus, supraoptic nucleus (SON), sexually dimorphic nucleus, the diagonal band of Broca, the nucleus basalis of Meynert, infundibular nucleus, ventromedial and dorsomedial nucleus, tuberomamillary nucleus, mamillary body, and paraventricular thalamic nucleus were observed to have neuronal MT1 receptor expression. No staining was observed in the nucleus tuberalis lateralis and bed nucleus of the stria terminalis. The MT1 receptor was colocalized with some vasopressin (AVP) neurons in the SCN, colocalized with some parvocellular and magnocellular AVP and oxytocine (OXT) neurons in the PVN and SON, and colocalized with some parvocellular corticotropin-releasing hormone (CRH) neurons in the PVN. In the pituitary, strong MT1 expression was observed in the pars tuberalis, while a weak staining was found in the posterior and anterior pituitary. These findings provide a neurobiological basis for the participation of melatonin in the regulation of various hypothalamic and pituitary functions. The colocalization of MT1 and CRH suggests that melatonin might directly modulate the hypothalamus-pituitary-adrenal axis in the PVN, which may have implications for stress conditions such as depression.
- Published
- 2006
20. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus
- Author
-
Trottier, S., Chotard, C., Traiffort, W., Unmehopa, U., Fisser, B., Swaab, D.F., Schwarts, J.C., Trottier, S., Chotard, C., Traiffort, W., Unmehopa, U., Fisser, B., Swaab, D.F., and Schwarts, J.C.
- Published
- 2002
21. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus
- Author
-
Trottier, S., primary, Chotard, C., additional, Traiffort, E., additional, Unmehopa, U., additional, Fisser, B., additional, Swaab, D.F., additional, and Schwartz, J.-C., additional
- Published
- 2002
- Full Text
- View/download PDF
22. Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.
- Author
-
Samsom KG, Bosch LJW, Schipper LJ, Schout D, Roepman P, Boelens MC, Lalezari F, Klompenhouwer EG, de Langen AJ, Buffart TE, van Linder BMH, van Deventer K, van den Burg K, Unmehopa U, Rosenberg EH, Koster R, Hogervorst FBL, van den Berg JG, Riethorst I, Schoenmaker L, van Beek D, de Bruijn E, van der Hoeven JJM, van Snellenberg H, van der Kolk LE, Cuppen E, Voest EE, Meijer GA, and Monkhorst K
- Subjects
- Humans, Workflow, Whole Genome Sequencing methods, Genomics, Biomarkers, Neoplasms diagnosis, Neoplasms genetics, Neoplasms pathology
- Abstract
Two decades after the genomics revolution, oncology is rapidly transforming into a genome-driven discipline, yet routine cancer diagnostics is still mainly microscopy based, except for tumor type-specific predictive molecular tests. Pathology laboratories struggle to quickly validate and adopt biomarkers identified by genomics studies of new targeted therapies. Consequently, clinical implementation of newly approved biomarkers suffers substantial delays, leading to unequal patient access to these therapies. Whole-genome sequencing (WGS) can successfully address these challenges by providing a stable molecular diagnostic platform that allows detection of a multitude of genomic alterations in a single cost-efficient assay and facilitating rapid implementation, as well as by the development of new genomic biomarkers. Recently, the Whole-genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE) study demonstrated that WGS is a feasible and clinically valid technique in routine clinical practice with a turnaround time of 11 workdays. As a result, WGS was successfully implemented at the Netherlands Cancer Institute as part of routine diagnostics in January 2021. The success of implementing WGS has relied on adhering to a comprehensive protocol including recording patient information, sample collection, shipment and storage logistics, sequencing data interpretation and reporting, integration into clinical decision-making and data usage. This protocol describes the use of fresh-frozen samples that are necessary for WGS but can be challenging to implement in pathology laboratories accustomed to using formalin-fixed paraffin-embedded samples. In addition, the protocol outlines key considerations to guide uptake of WGS in routine clinical care in hospitals worldwide., (© 2023. Springer Nature Limited.)
- Published
- 2024
- Full Text
- View/download PDF
23. Neuropeptide Y Signaling in the Lateral Hypothalamus Modulates Diet Component Selection and is Dysregulated in a Model of Diet-Induced Obesity.
- Author
-
Gumbs MCR, Eggels L, Kool T, Unmehopa UA, van den Heuvel JK, Lamuadni K, Mul JD, and la Fleur SE
- Subjects
- Animals, Diet, Dietary Fats, Hypothalamus metabolism, Male, Obesity, Rats, Rats, Wistar, Hypothalamic Area, Lateral metabolism, Neuropeptide Y metabolism
- Abstract
The preclinical multicomponent free-choice high-fat high-sucrose (fcHFHS) diet has strong validity to model diet-induced obesity (DIO) and associated maladaptive molecular changes in the central nervous system. fcHFHS-induced obese rats demonstrate increased sensitivity to intracerebroventricular infusion of the orexigenic Neuropeptide Y (NPY). The brain region-specific effects of NPY signaling on fcHFHS diet component selection are not completely understood. For example, fcHFHS-fed rats have increased intake of chow and fat following intracerebroventricular NPY infusion, whereas NPY administration in the nucleus accumbens, a key hub of the reward circuitry, specifically increases fat intake. Here, we investigated whether NPY infusion in the lateral hypothalamic area (LHA), which is crucially involved in the regulation of intake, regulates fcHFHS component selection, and if LHA NPY receptor subtypes 1 or 5 (NPYR1/5) are involved. Male Wistar rats were fed a chow or fcHFHS diet for at least seven days, and received intra-LHA vehicle or NPY infusions in a cross-over design. Diet component intake was measured two hours later. Separate experimental designs were used to test the efficacy of NPY1R- or NPY5R antagonism to prevent the orexigenic effects of intra-LHA NPY. Intra-LHA NPY increased caloric intake in chow- and fcHFHS-fed rats. This effect was mediated specifically by chow intake in fcHFHS-fed rats. The orexigenic effects of intra-LHA NPY were prevented by NPY1R and NPY5R antagonism in chow-fed rats, but only by NPY5R antagonism in fcHFHS-fed rats. Thus, NPY signaling has brain region-specific effects on fcHFHS component selection and LHA NPYR sensitivity is dysregulated during consumption of a fcHFHS diet., (Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
24. A free-choice high-fat diet modulates the effects of a sucrose bolus on the expression of genes involved in glucose handling in the hypothalamus and nucleus accumbens.
- Author
-
Koekkoek LL, Unmehopa UA, Eggels L, Kool T, Lamuadni K, Diepenbroek C, Mul JD, Serlie MJ, and la Fleur SE
- Subjects
- Animals, Glucose, Hypothalamus, Male, Rats, Rats, Wistar, Sucrose, Diet, High-Fat adverse effects, Nucleus Accumbens
- Abstract
The consumption of saturated fat and sucrose can have synergistic effects on the brain that do not occur when either nutrient is consumed by itself. In this study we hypothesize that saturated fat intake modulates glucose handling in the hypothalamus and nucleus accumbens, both brain areas highly involved in the control of food intake. To study this, male Wistar rats were given a free-choice high fat diet (fcHFD) or a control diet for two weeks. During the last seven days rats were given a daily bolus of either a 30% sucrose solution or water. Rats were sacrificed on day eight, 30 minutes after the onset of drinking. mRNA and protein levels of genes involved in glucose handling were assessed in the hypothalamus and nucleus accumbens. We found increased Glut3 and Glut4 mRNA in the hypothalamus of fcHFD-fed rats without an additional effect of the sucrose bolus. In the nucleus accumbens, the sucrose bolus increased Glut3 mRNA and decreased Glut4 mRNA independent of prior diet exposure. The ATP-sensitive potassium channel subunit Kir6.1 in the nucleus accumbens tended to be affected by the synergistic effects of a fcHFD and a sucrose bolus. These data suggest that acute glucose handling in the hypothalamus and nucleus accumbens may be affected by prior high fat exposure., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. One-week exposure to a free-choice high-fat high-sugar diet does not disrupt blood-brain barrier permeability in fed or overnight fasted rats.
- Author
-
Rijnsburger M, Unmehopa UA, Eggels L, Serlie MJ, and la Fleur SE
- Subjects
- Animals, Choice Behavior, Claudin-5 metabolism, Fasting, Male, Occludin metabolism, Rats, Wistar, Third Ventricle metabolism, Zonula Occludens-1 Protein metabolism, Blood-Brain Barrier metabolism, Diet, High-Fat, Dietary Sugars administration & dosage, Hypothalamus metabolism, Tight Junction Proteins metabolism
- Abstract
Objectives: The hypothalamus lies adjacent to the third ventricle and is in close proximity with the median eminence (ME), a circumventricular organ with an incomplete blood-brain barrier (BBB) which controls direct entry of nutrients into the brain. The blood-CSF barrier of the hypothalamus shows dynamic changes upon neuroendocrine events and adjusts permeability with the tight junction (TJ) complex. It has been shown that chronic exposure to a high-fat diet (HFD) affects BBB permeability. HFD also induces leptin resistance and alters neuropeptide expression in the arcuate nucleus (Arc) of the hypothalamus starting early during overnutrition. We hypothesized altered integrity of the BBB to occur after exposing rats to a free-choice high-fat high-sugar (fcHFHS) diet for 1 week. Methods: We measured diffusion of Evans blue dye over the ME and assessed expression of the TJ proteins ZO-1, claudin-5, and occludin in the tanycytic wall of the third ventricle. Furthermore, we assessed protein expression of glucose transporter 1 (GLUT-1), which is highly expressed in the Arc-ME complex and facilitates glucose transport over the BBB. Results: fcHFHS-fed rats increased caloric intake compared to control, however, there was no effect of the fcHFHS diet on permeability of the BBB, nor changes in protein expression of tight TJ proteins or GLUT-1. Fasting acutely affects the BBB and we hypothesized that exposure to the fcHFHS diet affects the BBB differently compared to chow after fasting. We did not, however, find any differences in Evans blue diffusion nor protein expression between chow- and fcHFHS-fed rats when fasted overnight. Conclusions: We conclude that short-term consumption of a fcHFHS diet does not change permeability or diffusion in the hypothalamus barrier in ad libitum fed or fasted rats.
- Published
- 2019
- Full Text
- View/download PDF
26. TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans.
- Author
-
Nies VJM, Struik D, Wolfs MGM, Rensen SS, Szalowska E, Unmehopa UA, Fluiter K, van der Meer TP, Hajmousa G, Buurman WA, Greve JW, Rezaee F, Shiri-Sverdlov R, Vonk RJ, Swaab DF, Wolffenbuttel BHR, Jonker JW, and van Vliet-Ostaptchouk JV
- Subjects
- Adaptor Proteins, Signal Transducing, Gene Frequency genetics, Humans, Metabolome genetics, Metabolome physiology, Metabolomics, Adipose Tissue metabolism, Hypothalamus metabolism, Obesity epidemiology, Obesity genetics, Obesity metabolism, Proteins analysis, Proteins genetics, Proteins metabolism
- Abstract
Background/objectives: Mutations in the Tubby gene (TUB) cause late-onset obesity and insulin resistance in mice and syndromic obesity in humans. Although TUB gene function has not yet been fully elucidated, studies in rodents indicate that TUB is involved in the hypothalamic pathways regulating food intake and adiposity. Aside from the function in central nervous system, TUB has also been implicated in energy metabolism in adipose tissue in rodents. We aimed to determine the expression and distribution patterns of TUB in man as well as its potential association with obesity., Subjects/methods: In situ hybridization was used to localize the hypothalamic regions and cells expressing TUB mRNA. Using RT-PCR, we determined the mRNA expression level of the two TUB gene alternative splicing isoforms, the short and the long transcript variants, in the hypothalami of 12 obese and 12 normal-weight subjects, and in biopsies from visceral (VAT) and subcutaneous (SAT) adipose tissues from 53 severely obese and 24 non-obese control subjects, and correlated TUB expression with parameters of obesity and metabolic health., Results: Expression of both TUB transcripts was detected in the hypothalamus, whereas only the short TUB isoform was found in both VAT and SAT. TUB mRNA was detected in several hypothalamic regions involved in body weight regulation, including the nucleus basalis of Meynert and the paraventricular, supraoptic and tuberomammillary nuclei. We found no difference in the hypothalamic TUB expression between obese and control groups, whereas the level of TUB mRNA was significantly lower in adipose tissue of obese subjects as compared to controls. Also, TUB expression was negatively correlated with indices of body weight and obesity in a fat-depot-specific manner., Conclusions: Our results indicate high expression of TUB in the hypothalamus, especially in areas involved in body weight regulation, and the correlation between TUB expression in adipose tissue and obesity. These findings suggest a role for TUB in human obesity.
- Published
- 2018
- Full Text
- View/download PDF
27. Effects of Fat and Sugar, Either Consumed or Infused toward the Brain, on Hypothalamic ER Stress Markers.
- Author
-
Belegri E, Rijnsburger M, Eggels L, Unmehopa U, Scheper W, Boelen A, and la Fleur SE
- Abstract
Protein-folding stress at the Endoplasmic Reticulum (ER) occurs in the hypothalamus during diet-induced obesity (DIO) and is linked to metabolic disease development. ER stress is buffered by the activation of the unfolded protein response (UPR), a controlled network of pathways inducing a set of genes that recovers ER function. However, it is unclear whether hypothalamic ER stress during DIO results from obesity related changes or from direct nutrient effects in the brain. We here investigated mRNA expression of UPR markers in the hypothalamus of rats that were exposed to a free choice high-fat high-sugar (fcHFHS) diet for 1 week and then overnight fed ad libitum , or fasted, or fat/sugar deprived (i.e., switched from obesogenic diet to chow). In addition, we determined the direct effects of fat/sugar on mRNA expression of hypothalamus UPR markers by intracarotic infusions of intralipids and/or glucose in chow-fed rats that were fasted overnight. Short term (1 week) exposure to fcHFHS diet increased adiposity compared to chow-feeding. Short term exposure to a fcHFHS diet, followed by mild food restriction overnight, induced hypothalamic ER stress in rats as characterized by an increase in spliced to unspliced X-box binding protein 1 mRNA ratio in hypothalamus of fcHFHS fed rats compared to chow fed rats. Moreover, infused lipids toward the brain of overnight fasted rats, were able to induce a similar response. Non-restricted ad libitum fcHFHS-diet fed or totally fasted rats did not show altered ratios. We also observed a clear increase in hypothalamic activating transcription factor 4 mRNA in rats on the fcHFHS diet while being ad libitum fed or when infused with intralipid via the carotic artery compared to vehicle infusions. However, we did not observe induction of downstream targets implying that this effect is a more general stress response and not related to ER stress. Overall, we conclude that the hypothalamic stress response might be a sensitive sensor of fat and energy status.
- Published
- 2017
- Full Text
- View/download PDF
28. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
- Author
-
Zhu QB, Unmehopa U, Bossers K, Hu YT, Verwer R, Balesar R, Zhao J, Bao AM, and Swaab D
- Subjects
- Aged, Aged, 80 and over, Alzheimer Disease pathology, Basal Nucleus of Meynert pathology, Female, Humans, Male, Middle Aged, Neurons metabolism, Neurons pathology, Single-Blind Method, Alzheimer Disease metabolism, Basal Nucleus of Meynert metabolism, Disease Progression, Early Growth Response Protein 1 biosynthesis, MicroRNAs biosynthesis
- Abstract
The cholinergic nucleus basalis of Meynert, which is important for memory functions, shows neuronal activation ('up-phase') during the early stages of Alzheimer's disease and neurodegeneration ('down-phase') in later stages of Alzheimer's disease. MicroRNA-132 (miR-132) and the transcription factor early growth response-1 (EGR1) were proposed as possible candidate molecules regulating such an up-down activity pattern of the nucleus basalis of Meynert during the course of Alzheimer's disease, as they both show this up-down pattern of expression in the prefrontal cortex during the course of Alzheimer's disease. Not only do these two molecules stimulate synaptic activity and plasticity, they are also involved in Alzheimer's disease pathology and might, in addition, affect cholinergic function. In the nucleus basalis of Meynert, we investigated the expression of miR-132 and EGR1 along the entire course of Alzheimer's disease. Forty-nine post-mortem nucleus basalis of Meynert samples were studied, ranging from non-demented controls (Braak stage = 0) to late Alzheimer's disease patients (Braak stage = VI), and from clinical Reisberg scale 1 to 7. Each Braak stage contained seven samples, that were all well matched for confounding factors, i.e. age (range 58-91), sex, post-mortem delay, cerebrospinal fluid pH (as a measure for agonal state), APOE genotype, clock time of death, tissue fixation time, and tissue storage time. The alterations of these two molecules were studied over the course of Alzheimer's disease in relation to the expression of 4G8-stained amyloid-β, hyperphosphorylated tau stained by antibody AT8, neuronal fibrillary tangles and neuropil threads stained by silver, and in relation to alterations in choline acetyltransferase. We found that the expression of miR-132 and EGR1 in the nucleus basalis of Meynert was quite stable during the early stages of Alzheimer's disease and decreased significantly only during late Alzheimer's disease stages. In addition, miR-132 and EGR1 showed a significant positive correlation with choline acetyltransferase expression (r = 0.49, P < 0.001 and r = 0.61, P < 0.001), while choline acetyltransferase expression showed a significantly negative correlation with hyperphosphorylated tau (r = -0.33, P = 0.021) but no correlation with 4G8-stained amyloid-β. From the functional changes of miR-132 and EGR1 along the course of Alzheimer's disease we conclude: (i) that these two molecules may play a role in keeping the cholinergic function intact in early Alzheimer's disease stages; and (ii) that these molecules may contribute to the late neurodegeneration of this cholinergic nucleus., (© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
29. Decreased hypothalamic prohormone convertase expression in huntington disease patients.
- Author
-
van Wamelen DJ, Aziz NA, Zhao J, Balesar R, Unmehopa U, Roos RA, and Swaab DF
- Subjects
- Aged, Female, Gene Expression Regulation genetics, Humans, Huntingtin Protein, Huntington Disease genetics, Hypothalamus pathology, Male, Middle Aged, Nerve Tissue Proteins genetics, Neurons metabolism, Neuropeptide Y metabolism, Proprotein Convertase 1 genetics, Proprotein Convertase 2 genetics, RNA, Messenger, Statistics, Nonparametric, Trinucleotide Repeats genetics, alpha-MSH genetics, alpha-MSH metabolism, Gene Expression Regulation physiology, Huntington Disease pathology, Hypothalamus metabolism, Proprotein Convertase 1 metabolism, Proprotein Convertase 2 metabolism
- Abstract
In Huntington disease (HD), hypothalamic neuropeptidergic systems are not equally affected at the peptide and mRNA levels. Because prohormone convertases (PCs) are critically involved in the conversion of propeptides into their active forms, we postulated that a decrease in PC expression may underlie these discrepancies. Therefore, we assessed the expression of PC1/3 and PC2 in the hypothalamic infundibular, suprachiasmatic, and paraventricular nuclei in postmortem tissues of HD patients and controls (n = 9, each) using immunocytochemistry and quantitative reverse transcription polymerase chain reaction. We also assessed PC1/3 and PC2 mRNA expression in the inferior frontal gyrus and colocalization of both PCs with corticotropin-releasing hormone and α-melanocyte-stimulating hormone. In HD patients, PC1/3 and PC2 expression was decreased in the hypothalamic infundibular (both p = 0.046) and paraventricular nuclei (p = 0.031 and p = 0.019). In the suprachiasmatic nucleus, PC1/3 and PC2 expressions were not different between HD and control cases; PC1/3 and PC2 mRNA levels in the inferior frontal gyrus were also not different. None of the PCs was colocalized with corticotropin-releasing hormone, whereas α-melanocyte-stimulating hormone showed colocalization with PC1/3 and PC2. These data suggest that defects in the processing of hypothalamic neuropeptides in HD may partially arise from decreased PC1/3 and PC2 expressions. These changes might contribute to selective neuropathology underlying various clinical manifestations and may provide novel therapeutic targets in HD patients.
- Published
- 2013
- Full Text
- View/download PDF
30. Stochastic loss of silencing of the imprinted Ndn/NDN allele, in a mouse model and humans with prader-willi syndrome, has functional consequences.
- Author
-
Rieusset A, Schaller F, Unmehopa U, Matarazzo V, Watrin F, Linke M, Georges B, Bischof J, Dijkstra F, Bloemsma M, Corby S, Michel FJ, Wevrick R, Zechner U, Swaab D, Dudley K, Bezin L, and Muscatelli F
- Subjects
- Alleles, Animals, Apnea genetics, Apnea pathology, Brain metabolism, Brain pathology, Disease Models, Animal, Gene Expression Regulation, Heterozygote, Humans, Mice, Mice, Knockout, Nerve Tissue Proteins metabolism, Nuclear Proteins metabolism, Prader-Willi Syndrome pathology, Promoter Regions, Genetic, Epigenesis, Genetic genetics, Genomic Imprinting, Nerve Tissue Proteins genetics, Nuclear Proteins genetics, Prader-Willi Syndrome genetics
- Abstract
Genomic imprinting is a process that causes genes to be expressed from one allele only according to parental origin, the other allele being silent. Diseases can arise when the normally active alleles are not expressed. In this context, low level of expression of the normally silent alleles has been considered as genetic noise although such expression has never been further studied. Prader-Willi Syndrome (PWS) is a neurodevelopmental disease involving imprinted genes, including NDN, which are only expressed from the paternally inherited allele, with the maternally inherited allele silent. We present the first in-depth study of the low expression of a normally silent imprinted allele, in pathological context. Using a variety of qualitative and quantitative approaches and comparing wild-type, heterozygous and homozygous mice deleted for Ndn, we show that, in absence of the paternal Ndn allele, the maternal Ndn allele is expressed at an extremely low level with a high degree of non-genetic heterogeneity. The level of this expression is sex-dependent and shows transgenerational epigenetic inheritance. In about 50% of mutant mice, this expression reduces birth lethality and severity of the breathing deficiency, correlated with a reduction in the loss of serotonergic neurons. In wild-type brains, the maternal Ndn allele is never expressed. However, using several mouse models, we reveal a competition between non-imprinted Ndn promoters which results in monoallelic (paternal or maternal) Ndn expression, suggesting that Ndn allelic exclusion occurs in the absence of imprinting regulation. Importantly, specific expression of the maternal NDN allele is also detected in post-mortem brain samples of PWS individuals. Our data reveal an unexpected epigenetic flexibility of PWS imprinted genes that could be exploited to reactivate the functional but dormant maternal alleles in PWS. Overall our results reveal high non-genetic heterogeneity between genetically identical individuals that might underlie the variability of the phenotype., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2013
- Full Text
- View/download PDF
31. Alterations in the histaminergic system in Alzheimer's disease: a postmortem study.
- Author
-
Shan L, Bossers K, Unmehopa U, Bao AM, and Swaab DF
- Subjects
- Aged, Aged, 80 and over, Autopsy, Female, Histamine N-Methyltransferase metabolism, Histidine Decarboxylase genetics, Humans, Hypothalamus metabolism, Male, Middle Aged, Neurons metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Receptors, Histamine genetics, Alzheimer Disease metabolism, Histamine metabolism, Histidine Decarboxylase metabolism, Receptors, Histamine metabolism
- Abstract
Histamine is produced by the hypothalamic tuberomamillary nucleus (TMN). We studied its involvement in Alzheimer's disease (AD) by in situ hybridization of histidine decarboxylase (HDC), the key enzyme of histamine production, in 9 AD patients and 9 controls. Additionally, messenger (m) RNA levels of the 4 histamine receptors (H(1-4)R) and of the enzyme involved in histamine metabolism, histamine methyltransferase (HMT), were determined by quantitative polymerase chain reaction (qPCR) in the prefrontal cortex (PFC) in the course of AD (n = 49). Moreover, alterations in glia markers were studied. HDC-mRNA levels in the TMN were unchanged in AD, despite of the reduced number of Nissl-stained neurons (p = 0.001). However, a decrease in HDC-mRNA was observed in its medial part (mTMN; p = 0.047). In the course of AD only females had increased prefrontal cortex expression of histamine receptor-3 (H(3)R) (p = 0.007) and histamine methyltransferase-mRNA (p = 0.011) and of the glia markers, glial fibrillary acidic protein-mRNA, vimentin-mRNA and proteolipid protein-mRNA. These findings indicate the presence of regional changes in the TMN that are at least partly gender-dependent., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
32. Ultrastructural localization and expression of TRPM1 in the human retina.
- Author
-
Klooster J, Blokker J, Ten Brink JB, Unmehopa U, Fluiter K, Bergen AA, and Kamermans M
- Subjects
- Eye Banks, Humans, Immunohistochemistry, In Situ Hybridization, Microscopy, Electron, Retina cytology, Retinal Bipolar Cells ultrastructure, Retinal Rod Photoreceptor Cells ultrastructure, Synapses metabolism, Synapses ultrastructure, TRPM Cation Channels genetics, Dendrites metabolism, Retina metabolism, Retinal Bipolar Cells metabolism, Retinal Rod Photoreceptor Cells metabolism, TRPM Cation Channels metabolism
- Abstract
Purpose: Transient receptor potential subfamily melastatin (TRPM)1 cation channels of retinal ON-bipolar cells are modulated via a mGluR6 (GMR6) signaling cascade. While light-microscopy shows these channels are located on the tips of ON-bipolar cells dendrites, near rod and cone synaptic ribbons, TRPM1 localization at the electron-microscope level is currently not described. The authors report here the ultrastructural localization of TRPM1 in the human retina., Methods: TRPM1 was localized in postmortem human retinas by immunohistochemistry at both the light and electron microscope levels. Additionally, TRPM1 expression was studied using in situ hybridization, laser dissection microscopy, and PCR techniques., Results: TRPM1-immunoreactivity was located on the dendrites and soma of ON-bipolar cells at the light microscope level. At the electron microscope level TRPM1-immunoreactivity was located on the tips of ON-bipolar cell dendrites that were invaginating cone pedicles and rod spherules. In addition, TRPM1-immunoreactivity was occasionally found on the rod spherules ribbons, suggesting that at least a proportion of rods may also express TRPM1. In situ hybridization showed TRPM1 encoding RNA in inner nuclear layer somata and in some photoreceptors. The presence of TRPM1-RNA in photoreceptors was confirmed by PCR in pure photoreceptor material obtained with a laser dissection microscope., Conclusions: In the human retina TRPM1 is expressed on ON-bipolar cell dendrites that invaginate photoreceptor terminals. TRPM1 is also expressed on the synaptic ribbons of a subclass of rods, suggesting a dual function for TRPM1 in the ON-pathway.
- Published
- 2011
- Full Text
- View/download PDF
33. Hypocretin and melanin-concentrating hormone in patients with Huntington disease.
- Author
-
Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, van Duinen S, Lammers GJ, Swaab D, and Roos R
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers analysis, Biomarkers metabolism, Cell Count, Cell Nucleus metabolism, Cell Nucleus pathology, Cerebral Cortex metabolism, Cerebral Cortex pathology, Cerebrospinal Fluid chemistry, Cerebrospinal Fluid metabolism, Cytoplasm metabolism, Cytoplasm pathology, Down-Regulation physiology, Female, Humans, Huntington Disease pathology, Hypothalamic Area, Lateral pathology, Immunohistochemistry, Inclusion Bodies metabolism, Inclusion Bodies pathology, Intracellular Signaling Peptides and Proteins analysis, Male, Middle Aged, Neurons pathology, Neuropeptides analysis, Orexins, Radioimmunoassay, Huntington Disease metabolism, Hypothalamic Area, Lateral metabolism, Hypothalamic Hormones metabolism, Intracellular Signaling Peptides and Proteins cerebrospinal fluid, Melanins metabolism, Neurons metabolism, Neuropeptides cerebrospinal fluid, Pituitary Hormones metabolism
- Abstract
To evaluate whether hypocretin-1 (orexin-A) and melanin-concentrating hormone (MCH) neurotransmission are affected in patients with Huntington disease (HD), we immunohistochemically stained hypocretin and MCH neurons and estimated their total numbers in the lateral hypothalamus of both HD patients and matched controls. In addition, hypocretin-1 levels were determined in prefrontal cortical tissue and post-mortem ventricular cerebrospinal fluid (CSF) using a radioimmunoassay. The total number of hypocretin-1 neurons was significantly reduced by 30% in HD brains (P = 0.015), while the total number of MCH neurons was not significantly altered (P = 0.100). Levels of hypocretin-1 were 33% lower in the prefrontal cortex of the HD patients (P = 0.025), but ventricular CSF levels were similar to the control values (P = 0.306). Neuronal intranuclear and cytoplasmic inclusions of mutant huntingtin were present in all HD hypothalami, although with a variable distribution across different hypothalamic structures. We found a specific reduction in hypocretin signaling in patients with HD as MCH cell number was not significantly affected. It remains to be shown whether the moderate decrease in hypocretin neurotransmission could contribute to clinical symptoms. As the number of MCH-expressing neurons was not affected, alterations in MCH signaling are unlikely to have clinical effects in HD patients.
- Published
- 2008
- Full Text
- View/download PDF
34. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone.
- Author
-
Wu YH, Zhou JN, Balesar R, Unmehopa U, Bao A, Jockers R, Van Heerikhuize J, and Swaab DF
- Subjects
- Adult, Aged, Female, Humans, Hypothalamus cytology, Immunohistochemistry, Male, Middle Aged, Neurons metabolism, Paraventricular Hypothalamic Nucleus cytology, Paraventricular Hypothalamic Nucleus metabolism, Pituitary Gland cytology, Corticotropin-Releasing Hormone metabolism, Hypothalamus metabolism, Melatonin metabolism, Oxytocin metabolism, Pituitary Gland metabolism, Receptor, Melatonin, MT1 metabolism, Vasopressins metabolism
- Abstract
Melatonin is implicated in numerous physiological processes, including circadian rhythms, stress, and reproduction, many of which are mediated by the hypothalamus and pituitary. The physiological actions of melatonin are mainly mediated by melatonin receptors. We here describe the distribution of the melatonin receptor MT1 in the human hypothalamus and pituitary by immunocytochemistry. MT1 immunoreactivity showed a widespread pattern in the hypothalamus. In addition to the area of the suprachiasmatic nucleus (SCN), a number of novel sites, including the paraventricular nucleus (PVN), periventricular nucleus, supraoptic nucleus (SON), sexually dimorphic nucleus, the diagonal band of Broca, the nucleus basalis of Meynert, infundibular nucleus, ventromedial and dorsomedial nucleus, tuberomamillary nucleus, mamillary body, and paraventricular thalamic nucleus were observed to have neuronal MT1 receptor expression. No staining was observed in the nucleus tuberalis lateralis and bed nucleus of the stria terminalis. The MT1 receptor was colocalized with some vasopressin (AVP) neurons in the SCN, colocalized with some parvocellular and magnocellular AVP and oxytocine (OXT) neurons in the PVN and SON, and colocalized with some parvocellular corticotropin-releasing hormone (CRH) neurons in the PVN. In the pituitary, strong MT1 expression was observed in the pars tuberalis, while a weak staining was found in the posterior and anterior pituitary. These findings provide a neurobiological basis for the participation of melatonin in the regulation of various hypothalamic and pituitary functions. The colocalization of MT1 and CRH suggests that melatonin might directly modulate the hypothalamus-pituitary-adrenal axis in the PVN, which may have implications for stress conditions such as depression.
- Published
- 2006
- Full Text
- View/download PDF
35. Individual differences in the expression of tyrosine hydroxylase mRNA in neurosecretory neurons of the human paraventricular and supraoptic nuclei: positive correlation with vasopressin mRNA.
- Author
-
Panayotacopoulou MT, Malidelis Y, van Heerikhuize J, Unmehopa U, and Swaab D
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Immunohistochemistry methods, In Situ Hybridization methods, Male, Middle Aged, Neurons enzymology, RNA, Messenger metabolism, Statistics as Topic, Tyrosine 3-Monooxygenase genetics, Gene Expression physiology, Neurons metabolism, Paraventricular Hypothalamic Nucleus cytology, Supraoptic Nucleus cytology, Tyrosine 3-Monooxygenase metabolism, Vasopressins genetics
- Abstract
Previous studies indicated that in the human paraventricular nucleus (PVN) and in the supraoptic nucleus (SON) tyrosine hydroxylase (TH) - the first and rate-limiting enzyme in catecholamine synthesis - is localized mainly in magnocellular neurosecretory neurons. Individual differences were observed among control subjects in number and distribution of TH-immunoreactive (IR) perikarya, indicating that antemortem factors may regulate TH expression. Since a large number of TH-IR perikarya were observed in subjects who suffered from somatic illnesses leading to prolonged osmotic or nonosmotic stimulation of vasopressin (VP) release, we suggested that TH expression is related to the activation of VP neurons. The purpose of our study was to apply (1) in situ hybridization for TH mRNA on human PVN and SON to investigate how the previously reported individual differences in TH protein expression are depicted at the transcriptional level and (2) quantitative TH immunohistochemistry and in situ hybridization for VP mRNA throughout the dorsolateral part of the SON (dl-SON) in order to elucidate whether indeed expression of TH in neurosecretory nuclei depends on activation of VP neurons. Postmortem formalin-fixed, paraffin-embedded hypothalamic sections of 16 control subjects were studied for TH protein and TH and VP mRNAs. For 6 of the above cases, the number of TH-IR neurons and the total VP mRNA levels were estimated throughout the entire dl-SON using an image analysis system. Individual variation was observed in TH mRNA expression which appears to parallel the expression of TH-protein. Using Spearman's bivariate test, a positive correlation was found between the number of TH-IR- and TH-mRNA-expressing neurons in both PVN and SON (p < 0.01) as well as between the number of TH-IR neurons and the total VP mRNA in the dl-SON (p < 0.05). Our results show (1) that the individual variability in the number of TH-IR neurons within the neurosecretory nuclei might be due to differential expression and/or stability of TH mRNA and (2) that expression of TH-immunoreactivity in human PVN and SON depends on the activation of VP neurons., (Copyright (c) 2005 S. Karger AG, Basel.)
- Published
- 2005
- Full Text
- View/download PDF
36. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression.
- Author
-
Zhou JN, Riemersma RF, Unmehopa UA, Hoogendijk WJ, van Heerikhuize JJ, Hofman MA, and Swaab DF
- Subjects
- Age of Onset, Aged, Arginine Vasopressin genetics, Arginine Vasopressin metabolism, Bipolar Disorder diagnosis, Bipolar Disorder metabolism, Cause of Death, Cell Count, Circadian Rhythm physiology, Depressive Disorder diagnosis, Depressive Disorder mortality, Female, Gene Expression, Humans, Male, Neurons chemistry, Neurons cytology, Neurons metabolism, RNA, Messenger analysis, RNA, Messenger metabolism, Suprachiasmatic Nucleus cytology, Suprachiasmatic Nucleus metabolism, Arginine Vasopressin analysis, Depressive Disorder metabolism, Suprachiasmatic Nucleus chemistry
- Abstract
Background: Circadian rhythm disturbances are frequently found in depressed subjects. Although it has been presumed that these disturbances may reflect a disorder of the circadian pacemaker, this has never been established. The suprachiasmatic nucleus (SCN) is the pacemaker of the circadian timing system in mammals, and arginine vasopressin (AVP) is one of its major neuropeptides. As peptide content is often taken as a measure for activity, we hypothesized that a decreased number of AVP-immunoreactive (AVP-IR) neurons and amount of AVP-messenger RNA (mRNA) would be present in the SCN of depressed subjects., Methods: Brains of 11 subjects suffering from major depression (8 cases) and bipolar disorder (3 cases), and of 11 controls, matched for sex, age, and clock time at death, were collected. The number of AVP-IR neurons in the SCN was determined by means of a digitizer (CalComp Inc, Reading, England). The amount of AVP-mRNA expression in the SCN was quantified with the Interaktive Bild Analyse System image analysis system (Kontron, Munich, Germany)., Results: In depressed subjects, the number of AVP-IR neurons in the SCN was more than one and a half times higher than in controls, while the total masked area of silver grains, as an estimate of the amount of AVP-mRNA, was about one half that of controls., Conclusions: Contrary to our hypothesis, an increase in the number of AVP-IR neurons in the SCN in depression was found, together with an expected decrease in AVP-mRNA. These findings suggest that, in depressed patients, both the synthesis and release of AVP in the SCN is reduced, resulting in an impaired functional ability. A disbalance between AVP production and transport needs further investigation in future studies.
- Published
- 2001
- Full Text
- View/download PDF
37. Metabolic activity of the human ventromedial nucleus neurons in relation to sex and ageing.
- Author
-
Ishunina TA, Unmehopa UA, van Heerikhuize JJ, Pool CW, and Swaab DF
- Subjects
- Adult, Aged, Aged, 80 and over, Analysis of Variance, Antibody Specificity, Cell Size, Female, Golgi Apparatus metabolism, Golgi Apparatus ultrastructure, Humans, Immunohistochemistry, Linear Models, Male, Middle Aged, Neurons ultrastructure, Sex Characteristics, Ventromedial Hypothalamic Nucleus ultrastructure, Aging metabolism, Neurons metabolism, Ventromedial Hypothalamic Nucleus metabolism
- Abstract
The ventromedial nucleus (VMN) in animals is involved in a number of sexually dimorphic behaviors, including reproduction, and is a well-documented target for sex steroids. In rats and in lizards, it is also characterized by the presence of structural sexual dimorphisms. In the present study, we determined whether the metabolic activity of human ventromedial nucleus neurons was sex- or age-related. The size of the immunocytochemically defined Golgi apparatus (GA) and cell profiles were determined as measures for neuronal metabolic activity in 12 male and 16 female control brains sub-divided into four groups with the dividing line being the age of 50. It appeared that the size of the GA relative to cell size was 34% larger in young women (<50 years old) than in young men and was 25% larger in elderly men (> or = 50 years old) than in young men. In addition, the GA/cell size ratio correlated significantly with age in men and not in women. Our data suggest that androgens play an inhibitory role with respect to the metabolic activity of the human VMN neurons.
- Published
- 2001
- Full Text
- View/download PDF
38. Decreased neuropeptide Y (NPY) expression in the infundibular nucleus of patients with nonthyroidal illness.
- Author
-
Fliers E, Unmehopa UA, Manniesing S, Vuijst CL, Wiersinga WM, and Swaab DF
- Subjects
- Adult, Aged, Aged, 80 and over, Brain metabolism, Feedback, Female, Humans, Immunohistochemistry, In Situ Hybridization, Leptin blood, Male, RNA, Messenger metabolism, Thyrotropin-Releasing Hormone metabolism, Arcuate Nucleus of Hypothalamus metabolism, Hypothalamus metabolism, Neuropeptide Y biosynthesis, Thyrotropin blood
- Abstract
In patients with a variety of illnesses, serum concentrations of T3 decrease without giving rise to elevated serum levels of TSH, a phenomenon known as the sick euthyroid syndrome or nonthyroidal illness (NTI). Our previous studies in postmortem brain material showed decreased thyrotropin-releasing hormone (TRH) messenger RNA (mRNA) in the paraventricular nucleus (PVN) of patients with NTI, suggesting a role for TRH cells in the persistence of low TSH levels in NTI. In the present study, we hypothesized that changes in neuropeptide Y (NPY) input from the infundibular nucleus (IFN) to TRH cells in the PVN might be a determinant of decreased TRH expression in NTI. We investigated the hypothalamus of nine patients whose endocrine status had been assessed in a serum sample taken less than 24h before death and we examined NPY expression in the IFN by means of immunocytochemistry and mRNA in situ hybridization using an image analysis system. There was a negative correlation (r = -0.88; p = 0.01) between serum leptin concentrations and total NPY mRNA in the IFN. The total amount of NPY immunoreactivity in the IFN correlated with total NPY mRNA (r = 0.69; p = 0.04). In contrast to the situation in food-deprived rodents, total NPY immunoreactivity in the IFN showed a positive correlation with total TRH mRNA in the PVN (r = 0.77; p = 0.02). The results suggest a role for decreased NPY input from the IFN in the resetting of thyroid hormone feedback on hypothalamic TRH cells in NTI.
- Published
- 2001
- Full Text
- View/download PDF
39. Multinucleated arginine-vasopressin neurons in the human supraoptic nucleus: a hallmark of pulmonary pathology.
- Author
-
Ishunina TA, Unmehopa UA, Dolzhikov AA, and Swaab DF
- Subjects
- Adult, Aged, Aged, 80 and over, Arginine Vasopressin biosynthesis, Arginine Vasopressin genetics, Female, Humans, Immunohistochemistry, In Situ Hybridization, Male, Middle Aged, Neurons chemistry, RNA, Messenger analysis, Arginine Vasopressin analysis, Cell Nucleus pathology, Lung Diseases pathology, Neurons ultrastructure, Supraoptic Nucleus ultrastructure
- Abstract
The human supraoptic nucleus (SON) is the main production site of plasma arginine-vasopressin (AVP). The present study aimed to define the subpopulation of patients in which multinucleated SON neurons (MNN) are present. We determined the proportion of MNN in immunocytochemically defined SON AVP population and compared AVP mRNA levels in the SON of 29 patients with and without MNN. Interestingly, MNN appeared to be present in a high proportion in patients with pneumonia and other pulmonary pathologies (Pul P). The percentage of MNN in the SON of Pul P patients turned out to be age- and sex-dependent. In young women with Pul P their proportion was 10 times higher than in women without such a pathology and in young men with Pul P their frequency was 22 times higher than in other men. In those patients with the highest proportion of MNN, i.e. young females and males with Pul P, AVP mRNA expression in the SON was the lowest. In addition, young women (less than or = 50 years old) had lower AVP mRNA levels than young men and than elderly women (>50 years old). In conclusion, our study suggests that multinucleated neurons are a hallmark of Pul P in the human SON and that this phenomenon may be accompanied by lower AVP production in young subjects.
- Published
- 2000
- Full Text
- View/download PDF
40. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression.
- Author
-
Liu RY, Zhou JN, Hoogendijk WJ, van Heerikhuize J, Kamphorst W, Unmehopa UA, Hofman MA, and Swaab DF
- Subjects
- Aged, Aged, 80 and over, Aging metabolism, Aging pathology, Alzheimer Disease metabolism, Alzheimer Disease pathology, Arginine Vasopressin deficiency, Arginine Vasopressin metabolism, Circadian Rhythm physiology, Female, Humans, In Situ Hybridization, Male, Middle Aged, RNA, Messenger analysis, RNA, Messenger biosynthesis, Severity of Illness Index, Suprachiasmatic Nucleus metabolism, Suprachiasmatic Nucleus pathology, Alzheimer Disease genetics, Arginine Vasopressin genetics, Circadian Rhythm genetics, Depression complications, Gene Expression
- Abstract
Circadian rhythm disturbances are frequently present in Alzheimer disease (AD). In the present study, we investigated the expression of vasopressin (AVP) mRNA in the human suprachiasmatic nucleus (SCN). The in situ hybridization procedure on formalin-fixed paraffin-embedded material was improved to such a degree that we could, for the first time, visualize AVP mRNA expressing neurons in the human SCN and carry out quantitative measurements. The total amount of AVP mRNA expressed as masked silver grains in the SCN was 3 times lower in AD patients (n = 14; 2,135 +/- 597 microm2) than in age- and time-of-death-matched controls (n = 11; 6,667 +/- 1466 microm2) (p = 0.003). No significant difference was found in the amount of AVP mRNA between AD patients with depression (n = 7) and without depression (n = 7) (2,985 +/-1103 microm2 and 1,285 +/- 298 microm2, respectively; p = 0.38). In addition, the human SCN AVP mRNA expressing neurons showed a marked day-night difference in controls under 80 years of age. The amount of AVP mRNA was more than 3 times higher during the daytime (9,028 +/- 1709 microm2, n = 7) than at night (2,536 +/- 740 microm2, n = 4; p = 0.02), whereas no clear diurnal rhythm of AVP mRNA in the SCN was observed in AD patients. There was no relationship between the amount of AVP mRNA in the SCN and age at onset of dementia, duration of AD and the neuropathological changes in the cerebral cortex. These findings suggest that the neurobiological basis of the circadian rhythm disturbances that are responsible for behavioral rhythm disorders is located in the SCN. It also explains the beneficial effects of light therapy on nightly restlessness in AD patients.
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.